Clinical Trial Update: Salivary Drug Concentration Exploratory Study of Cetylpyridinium Chloride Buccal Tablets [Phase 4]

View source ↗

Summary

An exploratory Phase 4 trial evaluating salivary drug concentrations from cetylpyridinium chloride buccal tablets for pharyngitis acute and gingivitis has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gingivitis
• Pharyngitis

Drugs mentioned

• cetylpyridinium chloride buccal tablets (cetylpyridinium chloride)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Pharyngitis Acute, Gingivitis | Phase 4 | Status: COMPLETED